These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15055990)

  • 21. 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
    Chen Y; Wen D; Huang Z; Huang M; Luo Y; Liu B; Lu H; Wu Y; Peng Y; Zhang J
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6867-70. PubMed ID: 23044371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete substitutional analysis of a sunflower trypsin inhibitor with different serine proteases.
    Hilpert K; Hansen G; Wessner H; Volkmer-Engert R; Höhne W
    J Biochem; 2005 Oct; 138(4):383-90. PubMed ID: 16272132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening.
    Cheon HG; Lee CM; Kim BT; Hwang KJ
    Bioorg Med Chem Lett; 2004 May; 14(10):2661-4. PubMed ID: 15109673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
    Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.
    De Cesco S; Deslandes S; Therrien E; Levan D; Cueto M; Schmidt R; Cantin LD; Mittermaier A; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2012 Jul; 55(14):6306-15. PubMed ID: 22765237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
    Borthwick AD; Weingarten G; Haley TM; Tomaszewski M; Wang W; Hu Z; Bedard J; Jin H; Yuen L; Mansour TS
    Bioorg Med Chem Lett; 1998 Feb; 8(4):365-70. PubMed ID: 9871686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
    Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
    Arasappan A; Padilla AI; Jao E; Bennett F; Bogen SL; Chen KX; Pike RE; Sannigrahi M; Soares J; Venkatraman S; Vibulbhan B; Saksena AK; Girijavallabhan V; Tong X; Cheng KC; Njoroge FG
    J Med Chem; 2009 May; 52(9):2806-17. PubMed ID: 19371095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
    Koo KD; Kim MJ; Kim S; Kim KH; Hong SY; Hur GC; Yim HJ; Kim GT; Han HO; Kwon OH; Kwon TS; Koh JS; Lee CS
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4167-72. PubMed ID: 17544668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.
    Jenkins TJ; Guan B; Dai M; Li G; Lightburn TE; Huang S; Freeze BS; Burdi DF; Jacutin-Porte S; Bennett R; Chen W; Minor C; Ghosh S; Blackburn C; Gigstad KM; Jones M; Kolbeck R; Yin W; Smith S; Cardillo D; Ocain TD; Harriman GC
    J Med Chem; 2007 Feb; 50(3):566-84. PubMed ID: 17266208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted piperazines as novel dipeptidyl peptidase IV inhibitors.
    Brockunier LL; He J; Colwell LF; Habulihaz B; He H; Leiting B; Lyons KA; Marsilio F; Patel RA; Teffera Y; Wu JK; Thornberry NA; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4763-6. PubMed ID: 15324904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors.
    Shiozaki M; Imai H; Maeda K; Miura T; Yasue K; Suma A; Yokota M; Ogoshi Y; Haas J; Fryer AM; Laird ER; Littmann NM; Andrews SW; Josey JA; Mimura T; Shinozaki Y; Yoshiuchi H; Inaba T
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6213-7. PubMed ID: 19767207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).
    Gomaa MS; Bridgens CE; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
    J Med Chem; 2011 Oct; 54(19):6803-11. PubMed ID: 21838328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential protease inhibitors based on a functionalized cyclic sulfamide scaffold.
    Zhong J; Gan X; Alliston KR; Lai Z; Yu H; Groutas CS; Wong T; Groutas WC
    J Comb Chem; 2004; 6(4):556-63. PubMed ID: 15244417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template.
    Borthwick AD; Angier SJ; Crame AJ; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Weingarten GG
    J Med Chem; 2000 Nov; 43(23):4452-64. PubMed ID: 11087570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric catalysis of homo-coupling of 3-substituted naphthylamine and hetero-coupling with 3-substituted naphthol leading to 3,3'-dimethyl-2,2'-diaminobinaphthyl and -2-amino-2'-hydroxybinaphthyl.
    Yusa Y; Kaito I; Akiyama K; Mikami K
    Chirality; 2010 Feb; 22(2):224-8. PubMed ID: 19408331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.